Back to Results
First PageMeta Content
Benign prostatic hyperplasia / Tadalafil / Prostate / CGMP-specific phosphodiesterase type 5 / Lower urinary tract symptoms / Alpha-1 blocker / Erectile dysfunction / PDE5 inhibitor / Urination / Medicine / Anatomy / Lactams


Special Feature Nippon Shinyaku Launches Zalutia®, a Breakthrough New Drug for Urinary Disorders Caused by Benign Prostatic Hypertrophy Benign prostatic hypertrophy, or BPH, negatively affects a patient’s quality of
Add to Reading List

Document Date: 2014-11-10 02:30:14

Open Document

File Size: 403,79 KB

Share Result on Facebook
UPDATE